Lercanidipine in patients with chronic renal failure: the ZAFRA Study

Lercanidipine in patients with chronic renal failure: the ZAFRA Study

Aim. To evaluate the safe use of a new calcium channel blocker, lercanidipine, in patients with chronic renal failure (CRF); the protective effect of calcium channel blocker on renal function in CRF patients previously treated with ACE inhibitors or angiotensin receptor blockers (ARB). Material and...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. R. Robles, J. Ocon, C. F. Gomez, M. Manjon, L. Pastor, J. Herrera, J. Villatoro, J. Calls, J. Torrijos, V. I. Rodríguez, M. M. A. Rodriguez, M. L. Mendez, A. Morey, F. I. Martinez, J. Marco, A. Liebana, B. Rincon, F. Tornero
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	lercanidipine chronic renal failure hypertension
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2108
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs
by: N. R. Robles, et al.
Published: (2011-06-01)

ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION TREATED WITH LERCANIDIPINE
by: J. Tisaire-Sánchez, et al.
Published: (2011-04-01)

CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01)

Lercanidipine in arterial hypertension
by: C. Borghi
Published: (1970-01-01)

LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01)

Lercanidipine Intoxication in A 16-Year-Old Adolescent
by: Volkan Bayar
Published: (2022-06-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
by: A. A. Shadrin, et al.
Published: (2019-01-01)

COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION
by: L. O. Minushkina
Published: (2013-10-01)

OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
by: E. L. Trisvetova
Published: (2015-09-01)

THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS
by: E. EL. Trisvetova
Published: (2015-09-01)

Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study
by: V. Barrios, et al.
Published: (1970-01-01)

Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice
by: Arrigo F.G. Cicero, et al.
Published: (2012-02-01)

Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine
by: O. V. Zimnitskaya, et al.
Published: (2016-11-01)

PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION
by: D. S. Kaskaeva, et al.
Published: (2017-03-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

Lercanidipine Enhances Cisplatin Activity: Dual Anticancer and Anti-Inflammatory Effects via Caspase Activation and MAPK Inhibition
by: Tugce Uskur, et al.
Published: (2025-04-01)

Study of Lercanidipine Drug Release from Medicine in Combination with Ramipril <i>in vitro</i> and <i>in vivo
by: A. A. Shadrin, et al.
Published: (2019-09-01)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
by: M. Dalla Vestra, et al.
Published: (1970-01-01)

Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
by: K. Makarounas-Kirchmann, et al.
Published: (2010-12-01)

ANTI-PROLIFERATIVE EFFECTIVENESS OF LERCANIDIPINE AND ITS MECHANISM OF ACTION (EXPERIMENTAL STUDY)
by: Jiunn-Ren Wu, et al.
Published: (2010-10-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Relationship between cardiac rhythm disorders, serum urotensin ІІ and angiotensin ІІ levels in patients with stage ii hypertension and carotid atherosclerosis in dynamics of treatment with candesartan and lercanidipine
by: O. V. Demidenko,, et al.
Published: (2016-10-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS AND THE TREATMENT OF ARTERIAL HYPERTENSION AND OBESITY PATIENTS IN ACCORDANCE WITH THE MODERN CLINICAL GUIDELINES
by: S. R. Gilyarevskyi, et al.
Published: (2014-04-01)

RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2017-01-01)

A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
by: E. I. Emelina, et al.
Published: (2015-11-01)

STROKE PREVENTION OPPORTUNITIES FOR CARDIOLOGISTS: COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION (ROLE OF CALCIUM ANTAGONISTS)
by: E. O. Taratukhin
Published: (2013-08-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy
by: E. O. Taratukhin
Published: (2013-06-01)

Lercanidipine in general practice settings: safety and effectiveness. The LAPSE Study results
by: N. R. Robles, et al.
Published: (2010-10-01)

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS
by: A. M. Shilov, et al.
Published: (2015-09-01)

Challenges in hypotensive therapy: the role of calcium antagonists
by: E. O. Taratukhin, et al.
Published: (2013-04-01)

ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OFLERCANIDIPINE IN DAILY CLINICAL PRACTICE. THE ELYPSE STUDY
by: Vivencio Barrios, et al.
Published: (2010-08-01)

FIXED ANTIHYPERTENSIVE DRUGS COMBINATION SELECTION WITH THE AIM OF ORGANS PROTECTION
by: O. D. Ostroumova, et al.
Published: (2015-05-01)

COMPARATIVE EFFECT OF LERCANIDIPINE, FELODIPINE, AND NIFEDIPINE GITS ON BLOOD PRESSURE AND HEART RATE IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION: THE LERCANIDIPINE IN ADULTS (LEAD) STUDY
by: R. Romito, et al.
Published: (2010-12-01)

Preparation and Evaluation of Lercanidipine HCl Nanosuspension to Improve the Dissolution Rate
by: Zahraa A. Alsafar, et al.
Published: (2025-02-01)

POTENCIALIDADES DE FAMILIAS DE VARIEDADES DE CAÑA DE AZÚCAR PARA DIFERENTES PERÍODOS DE ZAFRAS EN CUBA
by: Irenaldo Delgado Mora, et al.
Published: (2012-01-01)

Educación, religión y folklore en la celebración de fin de curso del Colegio María Inmaculada de Zafra (Badajoz). // Education, religion and folklore in celebration Prom. Mary Immaculate College of Zafra (Badajoz)
by: Valeriano Durán Manso
Published: (2016-05-01)

EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
by: M. A. Ninci, et al.
Published: (2016-01-01)

Quantitative Determination of Lercanidipine Enantiomers in Commercial Formulations by Capillary Electrophoresis
by: Luciana Pereira Lourenço, et al.
Published: (2015-01-01)